Fund holders13F
Funds That Own BIOCRYST PHARMACEUTICALS INC (BCRX)
2 of the 26 major funds we track reported BCRX in their latest 13F, worth $30.2M combined at quarter end.
| Fund | Quarter | Shares | Value | Change |
|---|---|---|---|---|
| Renaissance Technologies | Q2 2026 | 2,530,290 | $25.3M | ▲ +225.7% |
| Bridgewater Associates | Q2 2026 | 491,057 | $4.91M | ▼ −23.0% |
Source: SEC Form 13F-HR filings, retrieved Oct 28, 2026. How we read filings
A 13F lists long positions in U.S.-listed stocks and some options at quarter end. It does not show short positions, cash, most foreign holdings, or trades made since. What a 13F can't tell you →